180 related articles for article (PubMed ID: 9873535)
1. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.
Ogbu CO; Qabar MN; Boatman PD; Urban J; Meara JP; Ferguson MD; Tulinsky J; Lum C; Babu S; Blaskovich MA; Nakanishi H; Ruan F; Cao B; Minarik R; Little T; Nelson S; Nguyen M; Gall A; Kahn M
Bioorg Med Chem Lett; 1998 Sep; 8(17):2321-6. PubMed ID: 9873535
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
Maryanoff BE
J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
[No Abstract] [Full Text] [Related]
4. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis of benzisothiazolones as serine protease inhibitors.
Yu KL; Civiello R; Roberts DG; Seiler SM; Meanwell NA
Bioorg Med Chem Lett; 1999 Mar; 9(5):663-6. PubMed ID: 10201825
[TBL] [Abstract][Full Text] [Related]
6. Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface.
Katz BA; Finer-Moore J; Mortezaei R; Rich DH; Stroud RM
Biochemistry; 1995 Jul; 34(26):8264-80. PubMed ID: 7599119
[TBL] [Abstract][Full Text] [Related]
7. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
8. Secondary structure peptide mimetics: design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors.
Boatman PD; Ogbu CO; Eguchi M; Kim HO; Nakanishi H; Cao B; Shea JP; Kahn M
J Med Chem; 1999 Apr; 42(8):1367-75. PubMed ID: 10212122
[TBL] [Abstract][Full Text] [Related]
9. Inhibition activities of natural products on serine proteases.
Jedinák A; Maliar T; Grancai D; Nagy M
Phytother Res; 2006 Mar; 20(3):214-7. PubMed ID: 16521112
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors.
Bachand B; Tarazi M; St-Denis Y; Edmunds JJ; Winocour PD; Leblond L; Siddiqui MA
Bioorg Med Chem Lett; 2001 Feb; 11(3):287-90. PubMed ID: 11212093
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors: current status and future prospects.
Leung D; Abbenante G; Fairlie DP
J Med Chem; 2000 Feb; 43(3):305-41. PubMed ID: 10669559
[No Abstract] [Full Text] [Related]
12. Tryptase inhibition blocks airway inflammation in a mouse asthma model.
Oh SW; Pae CI; Lee DK; Jones F; Chiang GK; Kim HO; Moon SH; Cao B; Ogbu C; Jeong KW; Kozu G; Nakanishi H; Kahn M; Chi EY; Henderson WR
J Immunol; 2002 Feb; 168(4):1992-2000. PubMed ID: 11823536
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.
Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
Bioorg Med Chem Lett; 1998 Apr; 8(8):913-8. PubMed ID: 9871511
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties.
Supuran CT; Briganti F; Scozzafava A; Ilies MA
J Enzyme Inhib; 2000; 15(4):335-56. PubMed ID: 10995066
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors.
Rewinkel JB; Lucas H; Smit MJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
Bioorg Med Chem Lett; 1999 Oct; 9(19):2837-42. PubMed ID: 10522702
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors.
Ono S; Kuwahara S; Takeuchi M; Sakashita H; Naito Y; Kondo T
Bioorg Med Chem Lett; 1999 Dec; 9(23):3285-90. PubMed ID: 10612586
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-peptides derived from isomannide: inhibitors of serine proteases.
Barros TG; Pinheiro S; Williamson JS; Tanuri A; Gomes M; Pereira HS; Brindeiro RM; Neto JB; Antunes OA; Muri EM
Amino Acids; 2010 Mar; 38(3):701-9. PubMed ID: 19330426
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
Supuran CT; Scozzafava A; Briganti F; Clare BW
J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
Wienand A; Ehrhardt C; Metternich R; Tapparelli C
Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
[TBL] [Abstract][Full Text] [Related]
20. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
